Pat.2 ARID1B+/+ clone 2d (XX)
IMBAi017-A-2
General
Cell Line |
|
hPSCreg name | IMBAi017-A-2 |
Cite as: | IMBAi017-A-2 (RRID:CVCL_E4GY) |
Alternative name(s) |
Pat.2 ARID1B+/+ clone 2d (XX)
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines | No similar lines found. |
Last update | 28th August 2024 |
User feedback | |
Provider |
|
Generator | Institute of Molecular Biotechnology (IMBA) |
Derivation country | Austria |
External Databases |
|
BioSamples | SAMEA115960552 |
Cellosaurus | CVCL_E4GY |
General Information |
|
Publications | |
* Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: allowed
|
Subclone of |
Donor Information
General Donor Information |
|
Sex | female |
Phenotype and Disease related information (Donor) |
|
Diseases | A disease was diagnosed.
|
External Databases (Donor) |
|
BioSamples | SAMEA115296939 |
Ethics
Also have a look at the ethics information for the parental line
IMBAi017-A
.
Is there an MTA available for the cell line? | Yes |
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | |
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? | No |
hIPSC Derivation
General |
|
The source cell information can be found in the parental cell line
IMBAi017-A.
|
|
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Is reprogramming vector detectable? |
No |
Methods used |
RT-PCR
|
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
No |
Derived under GMP? |
No |
Available as clinical grade? |
No |
Culture Conditions
Surface coating | Matrigel/Geltrex |
Medium |
mTeSR™ Plus
|
Characterisation
No characterisation data could be found for this subclone. Please open parental cell line IMBAi017-A .Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
X X
|
Other Genotyping (Cell Line) |
Genetic Modification
Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.